Formula supplemented with docosahexaenoic acid (DHA) and arachidonic acid (ARA): a critical review of the research
- PMID: 16635189
- DOI: 10.1111/j.1744-6155.2006.00048.x
Formula supplemented with docosahexaenoic acid (DHA) and arachidonic acid (ARA): a critical review of the research
Abstract
Purpose: To summarize results of randomized controlled trials (RCTs) evaluating growth, cognitive, neurological, and visual development of term infants supplemented with docosahexaenoic acid (DHA) and arachidonic acid (ARA).
Design and methods: The Boyack and Lookinland Methodological Quality Index (MQI) was used to evaluate data from RCTs identified from multiple data bases.
Results: Six of ten studies found the addition of DHA and ARA to have no significant effect on infant development.
Practice implications: More expensive formula with endogenous DHA and ARA is not necessary. Results from longer studies currently underway will be beneficial.
Comment in
-
Sharing responsibilities to make evidence-based practice clinically feasible.J Spec Pediatr Nurs. 2006 Apr;11(2):77-9. doi: 10.1111/j.1744-6155.2006.00049.x. J Spec Pediatr Nurs. 2006. PMID: 16635186 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
